Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 801–900 of 1,000
The Double-Edged Flower: Roles of Complement Protein C1q in Neurodegenerative Diseases
Tenner, A. J., & Fonseca, M. I. (2007) · Springer eBooks · doi:10.1007/0-387-34134-x_11 · Cited by 34
Cutaneous Lupus Erythematosus: Molecular and Cellular Basis of Clinical Findings
Kuhn, A., & Sontheimer, R. D. (2008) · KARGER eBooks · doi:10.1159/000131451 · Cited by 33
Lu, J., Wu, X., & Teh, B. K. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.11.008 · Cited by 33
Raveau, M., Lignon, J. M., Nalesso, V., Duchon, A., Groner, Y., Sharp, A. J., Dembélé, D., Brault, V., & Hérault, Y. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002724 · Cited by 34
“In addition Amot, Ccne2, Cerk, C1qa and Fzd3 from group 4, could contribute to growth retardation and premature death [51,52].”
Incunabular Immunological Events in Prion Trafficking
Michel, B., Meyerett-Reid, C., Johnson, T., Ferguson, A. R., Wyckoff, C. A., Pulford, B. E., Bender, H., Avery, A. C., Telling, G. C., DOW, S. W., et al. (2012) · Scientific Reports · doi:10.1038/srep00440 · Cited by 33
Development of autoimmunity in mice lacking DNA topoisomerase 3β
Kwan, K. Y., Greenwald, R. J., Mohanty, S., Sharpe, A. H., Shaw, A. C., & Wang, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703587104 · Cited by 33
Lötscher, M., Recher, M., Hunziker, L., & Klein, M. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6040 · Cited by 37
“To test this hypothesis, transgenic mice lacking C1q (C57BL/6 C1qA / mice) (24) were given an i.”
BackgroundC1q: A Multifunctional Ligand for a New Immunoadsorption Treatment
Hiepe, F., Pfueller, B., Wolbart, K., Bruns, A., Leinenbach, H. P., Hepper, M., Schössler, W., & Otto, V. (1999) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1091-6660.1999.t01-2-.x · Cited by 33
The disposal of dying cells in living tissues
Manfredi, A. A., Iannacone, M., D׳Auria, F., & Rovere, P. Q. (2002) · APOPTOSIS · doi:10.1023/a:1014366531885 · Cited by 36
“C1q [45] Apoptosis in the kidneys of adult mice.”
BackgroundPutterman, C., Caricchio, R., Davidson, A., & Perlman, H. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/437282 · Cited by 39
Myelin debris phagocytosis in demyelinating disease
Gao, R., Song, S., Tian, M., Wang, L., Zhang, Y., & Li, X. (2024) · Glia · doi:10.1002/glia.24602 · Cited by 35
“Failure to remove apoptotic cells and cell debris, in addition to myelin debris, may trigger inflammation and the autoimmune characteristics of MS (Botto et al., 1998).”
McCubbrey, A. L., Sonstein, J., Ames, T. M., Freeman, C. M., & Curtis, J. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200984 · Cited by 35
“Conversely, the induction of lupus-like autoimmunity in mice by deletions of genes including C1q (40), MFG-E8 (41), av integrins (42, 43), and the TAM receptors (7, 44–46) argue for concurrent evolutionary”
BackgroundTemporal pattern of C1q deposition after transient focal cerebral ischemia
Mack, W. J., Sughrue, M. E., Ducruet, A. F., Mocco, J., Sosunov, S. A., Hassid, B. G., Silverberg, J. Z., Ten, V. S., Pinsky, D. J., & Connolly, E. S. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20775 · Cited by 32
“Infarcted brains from C1qa ( / ) knockout mice (Botto et al., 1998) were immunostained for C1q (not shown).”
Bengtsson, A. A., Nezlin, R. S., Shoenfeld, Y., & Sturfelt, G. K. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0300 · Cited by 32
Csencsits, K., Burrell, B. E., Lu, G., EICHWALD, E. J., Stahl, G. L., & Bishop, D. K. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02295.x · Cited by 32
“Breeder pairs of C1q-/- mice on a C57BL/6 (H-2b) background (C1qa-/-) (14)”
BackgroundGrossmayer, G. E., Munoz, L. E., Weber, C., Franz, S., Voll, R. E., Kern, P. M., Kalden, J. R., Schett, G. A., i, M. H., & Gaipl, U. S. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081828 · Cited by 32
Giacomin, P., Wang, H., Gordon, D., Botto, M., & Dent, L. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.11.7442-7449.2005 · Cited by 32
“in either C1q (classical pathway deficient) (3), factor B (alternative pathway”
BackgroundSelf-citationDecker, P. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.009 · Cited by 34
Fan, H., Longacre, A., Meng, F., Patel, V. A., Hsiao, K., Koh, J. S., & Levine, J. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4834 · Cited by 38
“Two recent models involving functional deletion of C1q or the Mer tyrosine kinase support this hypothesis (42, 43).”
Recent advances in the genetics of systemic lupus erythematosus
Gaffney, P. M., Moser, K. L., Graham, R., & Behrens, T. W. (2002) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00072-3 · Cited by 33
Windbichler, M., Echtenacher, B., Hehlgans, T., Jensenius, J. C., Schwaeble, W., & Männel, D. N. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5247-5252.2004 · Cited by 34
“C1qa / (2) and H2-Bf/C2 / (42) breeding pairs were obtained from Marina Botto (Imperial College School of Medicine, London, United Kingdom).”
BackgroundMethodTong, H. H., Li, Y. X., Stahl, G. L., & Thurman, J. M. (2010) · Infection and Immunity · doi:10.1128/iai.01012-09 · Cited by 31
“C57BL/6 mice homozygous for combined gene deficiencies of factor B and C2 (Bf/C2 / ) or C1qa (C1qa / ) were generated as described previously (2, 23), and breeding colonies of Bf/C2 / and C1qa /”
Method“Kill” the messenger: Targeting of cell-derived microparticles in lupus nephritis
Nielsen, C. T., Rasmussen, N. S., Heegaard, N. H. H., & Jacobsen, S. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.03.009 · Cited by 32
Molecular, Genetic and Epidemiologic Studies on Selective Complete C1q Deficiency in Turkey
van Berkel, A. I., Birben, E., Öner, C., Öner, R., Loos, M., & Petry, F. (2000) · Immunobiology · doi:10.1016/s0171-2985(00)80089-3 · Cited by 31
Self-citationCantaert, T., Rycke, L. D., Mavragani, C. P., Wijbrandts, C. A., Niewold, T. B., Niers, T. M. H., Vandooren, B., VEYS, E. M., Richel, D. J., Tak, P. P., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093724 · Cited by 31
11β-Hydroxysteroid dehydrogenase type 1—A role in inflammation?
Chapman, K. E., Gilmour, J. S., Coutinho, A. E., Savill, J., & Seckl, J. R. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.036 · Cited by 41
Zielinski, C. E., Jacob, S. N., Bouzahzah, F., Ehrlich, B. E., & Craft, J. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5100 · Cited by 31
“Identification of a lower threshold for activation in lupus T cells does not preclude other immune abnormalities from contributing to a predisposition to autoimmunity, such as in B cells (49, 50) or APC (42, 43, 51), or in clearance of apoptotic material (52).”
BackgroundGrader‐Beck, T., Casciola-Rosen, L. A., Lang, T., Puliaev, R., Rosen, A., & Via, C. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.95 · Cited by 31
A Central Role for αβ T Cells in the Pathogenesis of Murine Lupus
Seery, J. P., Wang, E. C. Y., Cattell, V., Carroll, J. M., Owen, M. J., & Watt, F. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7241 · Cited by 31
“production as has previously been reported in C57BL mice (11, 20).”
BackgroundApoptotic cell blebs: Repositories of autoantigens and contributors to immune context
Suber, T. L., & Rosen, A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24715 · Cited by 31
“Similarly, C1q deficiency appears to be accompanied by decreased clearance of apoptotic cells and systemic autoimmunity in both mice and humans (9).”
BackgroundAnti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review
Calatroni, M., Moroni, G. L., Conte, E., Stella, M., Reggiani, F., & Ponticelli, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1410032 · Cited by 32
C1qrs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis
Mosaad, Y. M., Hammad, A. M., Lotfy, Z. F., El-Refaey, A. M., Tawhid, Z., Hammad, E. M., Youssef, L. F., Elattar, E. A., Radwan, D. F., & Fawzy, I. M. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12666 · Cited by 30
The role of complement in the tumor microenvironment
Ain, D., Shaikh, T., Manimala, S., & Ghebrehiwet, B. (2021) · Faculty Reviews · doi:10.12703/r/10-80 · Cited by 32
Systemic lupus erythematosus—messages from experimental models
Stoll, M. L., & Gavalchin, J. (2000) · Rheumatology · doi:10.1093/rheumatology/39.1.18 · Cited by 32
Role of Complement in Protection againstCryptococcus gattiiInfection
Mershon, K. L., Vasuthasawat, A., Lawson, G. W., Morrison, S. L., & Beenhouwer, D. O. (2008) · Infection and Immunity · doi:10.1128/iai.01119-08 · Cited by 30
“C1q / mice were made by Mark Walport (The Wellcome Trust, London, United Kingdom) (2) and provided by Andrea Tenner (University of California, Irvine, CA).”
BackgroundMethodC1q-Dependent Dendritic Cell Cross-Presentation of In Vivo–Formed Antigen–Antibody Complexes
Ho, N. I., Camps, M. G. M., de Haas, E. F. E., Trouw, L. A., Verbeek, J. S., & OSSENDORP, F. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602169 · Cited by 30
“Verbeek, submitted for publication) and C1q-deficient (C1qa) mice were on a BL/6 genetic background (24).”
BackgroundRelevance of Anti‐C1q Autoantibodies to Lupus Nephritis
Tsirogianni, A., Pipi, E., & Soufleros, K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04750.x · Cited by 30
Genetics and systemic lupus erythematosus
Grossman, J. M., & Tsao, B. P. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-996-0063-x · Cited by 30
Therapeutic Inhibition of the Early Phase of Complement Activation
Roos, A., Ramwadhdoebé, T. H., Nauta, A. J., Hack, C. E., & Daha, M. R. (2002) · Immunobiology · doi:10.1078/0171-2985-00157 · Cited by 30
A Protective Role for Innate Immunity in Autoimmune Disease
Carroll, M. C. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4813 · Cited by 31
Benucci, M., Saviola, G., Baiardi, P., Cammelli, E., & Manfredi, M. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0728-5 · Cited by 30
“Apoptotic cells might represent a reservoir of autoantigen targeted in susceptible hosts [21], as a consequence of defective phagocytosis [22], and the failure of complement fractions [ 23 ] or pentraxins [24] can be involved in nucleosome accumulation.”
BackgroundRadic, M. Z., Shah, K., Zhang, W., Lu, Q., Lemke, G., & Hilliard, G. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.68 · Cited by 32
Intertwined pathways of complement activation command the pathogenesis of lupus nephritis
Satyam, A., Hisada, R., Bhargava, R., Tsokos, M., & Tsokos, G. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.03.005 · Cited by 31
Apoptotic cell death and lupus
Cohen, P. L. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0038-z · Cited by 32
“Essentially all C1q-deficient humans develop a lupus-like disease, and mice lacking C1q develop autoimmune disease with glomerulonephritis [43].”
BackgroundReduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus
Moosig, F., Damm, F., Knorr-Spahr, A., Ritgen, M., Zeuner, R. A., Kneba, M., Ernst, M., & Schröder, J. O. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03225.x · Cited by 32
Rahman, Z. S. M. (2011) · Immunologic Research · doi:10.1007/s12026-011-8248-4 · Cited by 34
Structural modification of DNA—a therapeutic option in SLE?
Frese, S., & Diamond, B. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.153 · Cited by 35
“Although the exact mechanisms that drive the generation of pathogenic autoantibodies in patients with SLE remain to be determined, it seems that defective clearance of apoptotic cells”
BackgroundMachida, T., Sakamoto, N., Ishida, Y., Takahashi, M., Fujita, T., & Sekine, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01191 · Cited by 29
Monogenic systemic lupus erythematosus: insights in pathophysiology
Batu, E. D. (2018) · Rheumatology International · doi:10.1007/s00296-018-4048-7 · Cited by 34
“In addition, C1q inhibited in vitro interferon alpha (IFNα) production by plasmacytoid dendritic cells [6].”
BackgroundHouser, S. L., Askenase, P. W., Palazzo, É., & Bloch, K. J. (2002) · Cardiovascular Pathology · doi:10.1016/s1054-8807(02)00107-2 · Cited by 29
“Isolated staining for C1q may reflect the role of this complement protein in binding to surface blebs of apoptotic endothelial cells [6–8].”
BackgroundIseki, M., Omori‐Miyake, M., Xu, W., Sun, X., Takaki, S., Rawlings, D. J., & Ziegler, S. F. (2012) · International Immunology · doi:10.1093/intimm/dxr113 · Cited by 30
Apoptosis, Complement and Systemic Lupus Erythematosus: A Mechanistic View
Liu, C. C., Navratil, J. S., Sabatine, J. M., & Ahearn, J. M. (2003) · KARGER eBooks · doi:10.1159/000075687 · Cited by 30
Dendritic cell and macrophage subsets in the handling of dying cells
Xu, W., Roos, A., Daha, M. R., & van Kooten, C. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.023 · Cited by 33
Tzeng, T.-C. J., Suen, J., & Chiang, B. (2006) · Rheumatology · doi:10.1093/rheumatology/kel106 · Cited by 28
Peltz, G., Zaas, A. K., Zheng, M., Solis, N. V., Zhang, M. X., Liu, H.-H., Hu, Y., Boxx, G. M., Phan, Q. T., Dill, D. L., et al. (2011) · Infection and Immunity · doi:10.1128/iai.05666-11 · Cited by 32
“Besides driving complement-dependent tissue inflammation, C1q is also a pattern recognition protein that facilitates the clearance of apoptotic cells (6, 15, 16, 33), and a deficiency in this activity could facilitate the development of autoimmunity.”
BackgroundBedoui, Y., Neal, J. W., & Gasque, P. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9793-6 · Cited by 29
Decreased production of immunoglobulin M and A in autoimmune pancreatitis
Taguchi, M., Kihara, Y., Nagashio, Y., Yamamoto, M., Otsuki, M., & Harada, M. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0106-y · Cited by 29
“Deficiency in secreted IgM has some effects on IgG antibody responses to both foreign antigen and self-antigen because of a deficiency in complement [ 22 ].”
BackgroundB cell diversity and longevity in systemic autoimmunity
Zouali, M. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00016-0 · Cited by 28
Deng, Y., Hahn, B. H., & Tsao, B. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00081-1 · Cited by 28
Apoptosis: from Signalling Pathways to Therapeutic Tools
Mousavi, S. H., Tayarani‐Najaran, Z., & Hersey, P. (2015) · Cited by 35
An update on pathogenesis of systemic lupus erythematosus.
Ahmadpoor, P., Dalili, N., & Rostami, M. (2014) · Iranian Journal of Kidney Diseases · Cited by 37
Yamamoto, N., Yamaguchi, H., Ohmura, K., Yokoyama, T., Yoshifuji, H., Yukawa, N., Kawabata, D., Fujii, T., Morita, S., Nagata, S., et al. (2014) · Lupus · doi:10.1177/0961203314523870 · Cited by 27
Hassan, A. O., Dmitriev, I. P., Kashentseva, E. A., Zhao, H., Brough, D. E., Fremont, D. H., Curiel, D. T., & Diamond, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.005 · Cited by 29
“C57BL/6 mice were purchased from The Jackson Laboratory (catalog 000664), and congenic hSTAT2-KI (Gorman et al., 2018) and C1q −/− mice (Botto et al., 1998) were bred in pathogen-free animal facilities at Washington University School of Medicine.”
Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis
Genest, D. S., Bonnefoy, A., Khalili, M., Merlen, C., Genest, G., Lapeyraque, A., Patey, N., Smail, N., Royal, V., & Troyanov, S. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.02.002 · Cited by 27
“Conversely, complement deficiencies can contribute to glomerular injury, further complexifying our understanding of complement in GN.(44,45) Although animal studies have detailed many mechanisms of complement activation in glomerulopathies, corroborating which ones are most relevant in the clinical setting is lacking,…”
BackgroundInfluentialWang, L., Yang, Z., Yu, H., Lin, W., Wu, R., Yang, H., & Yang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839197 · Cited by 29
Death receptor 6 contributes to autoimmunity in lupus-prone mice
Fujikura, D., Ikesue, M., Endo, T., Chiba, S., Higashi, H., & Uede, T. (2017) · Nature Communications · doi:10.1038/ncomms13957 · Cited by 27
The Deadly Dance of B Cells with Trypanosomatids
Silva‐Barrios, S., Charpentier, T., & Stäger, S. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.10.001 · Cited by 30
Unexpected Roles for Intracellular Complement in the Regulation of Th1 Responses
West, E. E., Afzali, B., & Kemper, C. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.02.001 · Cited by 27
Complement C4A Regulates Autoreactive B Cells in Murine Lupus
Simoni, L., Présumey, J., van der Poel, C. E., Castrillon, C. E., Chang, S. E., Utz, P. J., & Carroll, M. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108330 · Cited by 28
“Similar to humans, mice deficient in C1q or C4 spontaneously develop lupus-like disease (Botto et al., 1998; Fischer et al., 1996), and this phenotype correlates with the defective clearance of apoptotic cells by peritoneal Simoni et al.”
BackgroundInfluentialShah, D., Romero, F., Zhu, Y., Duong, M., Sun, J., Walsh, K. X., & Summer, R. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.690784 · Cited by 27
“The disrupted murine C1qa gene was backcrossed for seven generations onto the C57BL/6 strain (20).”
BackgroundMethodInfluentialRecruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis
Balasubramanian, K., Maiti, S. N., & Schroit, A. J. (2005) · APOPTOSIS · doi:10.1007/s10495-005-0817-3 · Cited by 27
The complement system in prion diseases
Mabbott, N. A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.002 · Cited by 27
Links Between Type I Interferons and the Genetic Basis of Disease in Mouse Lupus
Jørgensen, T. N., Bupp, M. G., & Kotzin, B. L. (2003) · Autoimmunity · doi:10.1080/08916930310001605864 · Cited by 29
Host-Specific Serum Factors Control the Development and Survival of Schistosoma mansoni
Anisuzzaman, A., Frahm, S., Prodjinotho, U. F., Bhattacharjee, S., Verschoor, A., & da Costa, C. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635622 · Cited by 26
Freiwald, T., & Afzali, B. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.001 · Cited by 27
Apoptotic membrane dynamics in health and disease
Olson, M. F., & Julian, L. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s57893 · Cited by 31
“90 Nevertheless, animal model studies have revealed that not all defects in apoptotic clearance mechanisms lead to autoimmunity.”
Complement in Glomerular Disease
Vernon, K. A., & Cook, H. T. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.02.015 · Cited by 27
“Indeed, C1q deficiency results in autoimmunity with impaired apoptotic cell clearance and the presence of glomerular apoptotic bodies.(10) In accelerated nephrotoxic nephritis, an IC-mediatedmodel of glomerular inflammation, increased glomerular murine IgG and apoptotic cell deposits were seen in mice with C1q deficie…”
BackgroundSelf-citationBaruah, P., Simpson, E., Dumitriu, I. E., Derbyshire, K., Coe, D., Addey, C., Dyson, J., Chai, J., Cook, T. H., Scott, D. M., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200940158 · Cited by 26
Self-citationNiaudet, P., & Salomon, R. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_47 · Cited by 26
Lupus pathobiology based on genomics
Saeed, M. (2016) · Immunogenetics · doi:10.1007/s00251-016-0961-7 · Cited by 30
“SLE develops in over 90% of C1q-deficient individuals though complete deficiency of C1q is rare (Botto et al. 1998).”
BackgroundInfluentialSurface complement C3 fragments and cellular binding of microparticles in patients with SLE
Winberg, L. K., Nielsen, C. H., & Jacobsen, S. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000193 · Cited by 26
Kiriakidis, S., Hoer, S., Burrows, N., Biddlecome, G. H., Khan, M. N., Thinnes, C. C., Schofield, C. J., Rogers, N. E., Botto, M., Paleolog, E. M., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.008 · Cited by 26
“Mice with defective phd and c1q alleles were previously described.(40,41) For inhibitor studies, male and female C57BL/6 mice”
MethodSelf-citationLe lupus érythémateux disséminé de l'enfant
Bader‐Meunier, B., Quartier, P., Deschênes, G., Cochat, P., Haddad, É., Koné‐Paut, I., Leblanc, T. M., Prieur, A., Salomon, R., Bodemer, C., et al. (2003) · Archives de Pédiatrie · doi:10.1016/s0929-693x(03)00313-0 · Cited by 26
Apoptosis and autoimmunity: Complement deficiency and systemic lupus erythematosus revisited
Navratil, J. S., & Ahearn, J. M. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-996-0066-7 · Cited by 27
‘Centennial’ Nobel Conference on apoptosis and human disease
Robertson, J. D., Fadeel, B., Zhivotovsky, B., & Orrenius, S. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401014 · Cited by 29
C3 Drives Inflammatory Skin Carcinogenesis Independently of C5
Jackson, W. D., Gulino, A., Fossati‐Jimack, L., Seoane, R. C., Tian, K., Best, K., Köhl, J., Belmonte, B., Strid, J., & Botto, M. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.06.025 · Cited by 27
“, 1995), C1qa / (Botto et al., 1998), C5ar1 / (Höpken et al.”
Self-citationDing, Q. J., Cook, A. C., Dumitrescu, A. V., & Kuehn, M. H. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10442 · Cited by 25
“C1q, the initiator of the classical complement cascade, is a crucial component of this opsonin-mediated phagocytotic process and loss of C1q results in delayed clearance of apoptotic cell debris.(10) Genetic deficiencies in C1q and other early components of the classical complement cascade result not only in enhanced…”
BackgroundAltered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus
Berkun, Y., Verbovetski, I., Ben‐Ami, A., Paran, D., Caspi, D., Krispin, A., Trahtemberg, U., Gill, O., Naparstek, Y., & Mevorach, D. (2008) · European Journal of Immunology · doi:10.1002/eji.200838342 · Cited by 27
Lewis, M., Malik, T. H., Fossati‐Jimack, L., Carassiti, D., Cook, H. T., Haskard, D. O., & Botto, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34451 · Cited by 28
“apoptotic cells (9), which is considered to be a key”
BackgroundSelf-citationAssessing association of common variation in the C1Q gene cluster with systemic lupus erythematosus
Rafiq, S., Frayling, T. M., Vyse, T. J., Graham, D. S. C., & Eggleton, P. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04185.x · Cited by 25
Dysregulated homeostasis of target tissues or autoantigens - A novel principle in autoimmunity
Petersen, F., Yue, X., Riemekasten, G., & Yu, X. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.04.006 · Cited by 26
Common and rare genetic variants of complement components in human disease
de Jorge, E. G., López‐Lera, A., Bayarri‐Olmos, R., Yébenes, H., López‐Trascasa, M., & de Córdoba, S. R. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.011 · Cited by 28
Experimental Models of Lupus Nephritis
Grande, J. P. (2011) · Contributions to nephrology · doi:10.1159/000319241 · Cited by 27
Lachmann, P. J. (2003) · Lupus · doi:10.1191/0961203303lu357xx · Cited by 25
Intact B cell tolerance in the absence of the first component of the classical complement pathway
Cutler, A. J., Cornall, R. J., Ferry, H., Manderson, A. P., Botto, M., & Walport, M. J. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2087::aid-immu2087>3.0.co;2-c · Cited by 25
Self-citationHistopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice
Jacob, M. I., Napirei, M., Ricken, A. M., Dixkens, C., & Mannherz, H. G. (2002) · Lupus · doi:10.1191/0961203302lu242oa · Cited by 26
Qasim, M., Rahman, H., Oellerich, M., & Asif, A. R. (2011) · Proteome Science · doi:10.1186/1477-5956-9-57 · Cited by 26
“C1q deficiency leads to a significant decline in the clearance of apoptotic cells in both C1q- and C4-deficient mice, causing glomerulonephritis [56].”
BackgroundPhagocytic clearance of apoptotic cells: role in lung disease
Yun, J. H., Henson, P. M., & Tuder, R. M. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.6.753 · Cited by 27
“Botto M, Dell’Agnola C, Bygrave AE 54 et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19(1), 56–59 (1998).”
BackgroundCarlucci, F., Ishaque, A., Ling, G. S., Szajna, M., Sandison, A., DONATIEN, P. D., Cook, H. T., & Botto, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1401009 · Cited by 24
“impaired clearance of apoptotic cells in the disease pathogenesis (2).”
BackgroundMethodSelf-citationHuman Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against Neisseria gonorrhoeae
Shaughnessy, J., Lewis, L. A., Zheng, B., Carr, C. R., Bass, I., Gulati, S., DeOliveira, R. B., Gose, S. O., Reed, G. W., Botto, M., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701666 · Cited by 24
“Efficacy of FH6,7/Fc and FHD1119G/Fc against strain FA1090 was also evaluated in C1q-deficient mice (C1q mice) on the C57BL/6 background (42) and in transgenic (Tg) mice that expressed HuFH and human C4b-binding protein (C4BP) on the BALB/c background (43).”
BackgroundSelf-citation
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.